Belén Rueda de Lecea

Belén Rueda de lecea has a diverse work experience spanning multiple industries. Belén is currently employed at Centrient Pharmaceuticals, where they began as a Strategic Planning Director in October 2022 before being promoted to Global Head of Strategic Planning and PMO in July 2023. Prior to that, they worked at Bristol Myers Squibb as a Business Insights & Analytics, Oncology Lead from April 2021 to October 2022. Before entering the healthcare industry, Belén worked at Kearney from 2016 to 2021, starting as a Senior Business Analyst and eventually becoming a Manager. During their time at Kearney, they led cross-functional teams and managed various projects, including developing a business plan for a technology company, assessing M&A targets, and implementing supply management systems for pharmaceutical companies. Belén also gained experience as a Consultant at Aguirre Newman from December 2012 to September 2014. Belén began their career as a Summer Associate at A.T. Kearney in June 2015. Overall, Belén has demonstrated strong strategic planning, project management, and consulting skills throughout their career.

Belén Rueda de Lecéa has a diverse education history. In 2006 to 2012, they attended the Universidad Politécnica de Madrid and earned a degree in Architecture/Civil Engineering. In 2010 to 2011, they pursued further studies at the Illinois Institute of Technology, obtaining a Bachelor of Architecture (B.Arch.). Belén later pursued business studies, completing a Master of Business Administration (MBA) at both IESE Business School and Yale School of Management in 2014 to 2016 and 2015 to 2016, respectively. In terms of additional certifications, Belén obtained an Agile Scrum Certification from the Master of Project Academy in 2020. Furthermore, they obtained a GMAT score of 740 in 2013 and achieved TOEFL proficiency in the same year. Belén also holds a Certificate in Advanced English from Cambridge Assessment English, obtained in 2007.